InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the detailed record of transactions filed by O'Brien Stephanie Monaghan, Director. Officer active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 7 filings have been published. History available since 1 January 2022. The latest transaction was disclosed on 6 April 2026 (J). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to O'Brien Stephanie Monaghan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
25,666 股Common StockSEC:0001193125-26-224592:0
5,750 股0Common StockSEC:0001492422-26-000099:0
7,961 股0Common StockSEC:0001492422-26-000011:0
6,267 股0Common StockSEC:0001127602-25-000440:0
3,341 股0Common StockSEC:0001127602-24-000118:0
3,867 股0Common StockSEC:0000899243-23-000672:0
4,230 股0Common StockSEC:0001127602-22-000497:0
7 条申报中的 7 条
About O'Brien Stephanie Monaghan
Stephanie Monaghan O'Brien is a Director at Apellis Pharmaceuticals, Inc. She brings expertise in management and business strategy to the board. Her role is essential in guiding strategic decisions and ensuring the sustainable growth of the company.
